Biotech | January 29, 2022
Israel signs deal to purchase Novavax’ Covid-19 vaccine
It would be the first protein-based alternative available in Israel
It would be the first protein-based alternative available in Israel
Evrysdi is approved in 70 countries and submitted in a further 31 with more than 4,500 patients treated to date
New data from ongoing trial showed increased antibody response against Beta, Delta, Alpha, Gamma and Omicron variants following third dose booster with Vaxzevria
Novavax' vaccine has received authorizations of the vaccine in over 170 countries
Emergency Use Authorisation application request to be submitted following one month required by FDA EUA guidance
Covaxin is formulated uniquely such that the same dosage can be administered to adults and children
Alzheimer's disease is a serious, progressive and devastating disease with few treatment options
Trastuzumab is monoclonal antibody used to treat human epidermal growth factor receptor 2 positive (HER2+) breast cancer and metastatic gastric cancers
The Indian Council of Medical Research (ICMR), intends to enter into non-exclusive agreements with companies
EMA’s CHMP advice states that Paxlovid can be used for treatment of adults with Covid-19 who do not require supplemental oxygen and who are at increased risk of progressing to severe disease
Subscribe To Our Newsletter & Stay Updated
